{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:04Z","timestamp":1761896584948,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ahj.2017.06.011","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T14:16:16Z","timestamp":1498572976000},"page":"76-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3"],"prefix":"10.1016","volume":"192","author":[{"given":"Ron","family":"Waksman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Steinvil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"DiFilippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasvindar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"DeBruin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Jolivette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.ahj.2017.06.011_bb0005","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.ahj.2017.06.011_bb0010","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2017.06.011_bb0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1751-7176.2012.00699.x","article-title":"A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the World Health Organization multidimensional adherence model","volume":"14","author":"AlGhurair","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"12","key":"10.1016\/j.ahj.2017.06.011_bb0020","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00392-011-0335-y","article-title":"Sympatho-renal axis in chronic disease","volume":"100","author":"Sobotka","year":"2011","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"10.1016\/j.ahj.2017.06.011_bb0025","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1161\/CIRCRESAHA.114.302524","article-title":"The autonomic nervous system and hypertension","volume":"114","author":"Mancia","year":"2014","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.ahj.2017.06.011_bb0030","doi-asserted-by":"crossref","first-page":"F583","DOI":"10.1152\/ajprenal.00246.2015","article-title":"Renal denervation for the treatment of resistant hypertension: review and clinical perspective","volume":"309","author":"Iliescu","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9671","key":"10.1016\/j.ahj.2017.06.011_bb0035","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"issue":"9917","key":"10.1016\/j.ahj.2017.06.011_bb0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","article-title":"Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study","volume":"383","author":"Krum","year":"2014","journal-title":"Lancet"},{"issue":"9756","key":"10.1016\/j.ahj.2017.06.011_bb0045","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial","volume":"376","author":"Symplicity HTN Investigators","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ahj.2017.06.011_bb0050","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jash.2015.10.002","article-title":"Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial","volume":"9","author":"Yerasi","year":"2015","journal-title":"J Am Soc Hypertens"},{"issue":"15","key":"10.1016\/j.ahj.2017.06.011_bb0055","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ahj.2017.06.011_bb0060","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2015.01.037","article-title":"12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial","volume":"65","author":"Bakris","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2017.06.011_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","article-title":"Predictors of blood pressure response in the SYMPLICITY HTN-3 trial","volume":"36","author":"Kandzari","year":"2015","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ahj.2017.06.011_bb0070","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jash.2015.08.001","article-title":"An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial","volume":"9","author":"Flack","year":"2015","journal-title":"J Am Soc Hypertens"},{"issue":"46","key":"10.1016\/j.ahj.2017.06.011_bb0075","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1093\/eurheartj\/ehu364","article-title":"Non-adherence to cardiovascular medications","volume":"35","author":"Kolandaivelu","year":"2014","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2017.06.011_bb0080","first-page":"834","article-title":"Geographic variation in medication adherence in commercial and Medicare part D populations","volume":"20","author":"Couto","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.ahj.2017.06.011_bb0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/clc.22217","article-title":"Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry","volume":"36","author":"Rodriguez","year":"2013","journal-title":"Clin Cardiol"},{"issue":"578","key":"10.1016\/j.ahj.2017.06.011_bb0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3399\/bjgp10X515403","article-title":"Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements","volume":"60","author":"Warren","year":"2010","journal-title":"Br J Gen Pract"},{"issue":"18","key":"10.1016\/j.ahj.2017.06.011_bb0095","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jacc.2016.07.775","article-title":"Regression to the mean in SYMPLICITY HTN-3: implications for design and reporting of future trials","volume":"68","author":"Pocock","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2017.06.011_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijcard.2013.12.183","article-title":"Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions","volume":"172","author":"Howard","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2017.06.011_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.115.002533","article-title":"Quantifying the 3 biases that lead to unintentional Overestimation of the blood pressure\u2013lowering effect of renal denervation","volume":"9","author":"Howard","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2017.06.011_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7473","article-title":"Resistant hypertension","volume":"345","author":"Myat","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2017.06.011_bb0115","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.ejim.2013.08.072","article-title":"Pseudo-resistant hypertension: a hard dilemma for clinical practice","volume":"24","author":"Toporan","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.ahj.2017.06.011_bb0120","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.0000154900.76284.F6","volume":"111","author":"Pickering","year":"2005","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ahj.2017.06.011_bb0125","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000160923.04524.5B","article-title":"Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study","volume":"111","author":"Sega","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2017.06.011_bb0130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"de la Sierra","year":"2011","journal-title":"Hypertension"},{"year":"2003","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"World Health Organization","key":"10.1016\/j.ahj.2017.06.011_bb0135"},{"issue":"4","key":"10.1016\/j.ahj.2017.06.011_bb0140","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension? Assessment of adherence by toxicological urine analysis","volume":"31","author":"Jung","year":"2013","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.ahj.2017.06.011_bb0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.06.011_bb0150","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2014.05.012","article-title":"Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3","volume":"64","author":"Bakris","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9981","key":"10.1016\/j.ahj.2017.06.011_bb0155","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","article-title":"Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial","volume":"385","author":"Azizi","year":"2015","journal-title":"Lancet"},{"issue":"10000","key":"10.1016\/j.ahj.2017.06.011_bb0160","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(15)00258-5","article-title":"Renal denervation for resistant hypertension","volume":"386","author":"Mircheva","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ahj.2017.06.011_bb0165","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/HJH.0b013e328362152e","article-title":"Eligibility for percutaneous renal denervation: the importance of a systematic screening","volume":"31","author":"Verloop","year":"2013","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.ahj.2017.06.011_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149855","article-title":"Impact of renal sympathetic denervation on left ventricular structure and function at 1-year follow-up","volume":"11","author":"de Sousa Almeida","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ahj.2017.06.011_bb0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ahj.2015.08.021","article-title":"The SPYRAL HTN Global Clinical Trial Program: rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications","volume":"171","author":"Kandzari","year":"2016","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2017.06.011_bb0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4244\/EIJV9I1A11","article-title":"Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial","volume":"9","author":"Ormiston","year":"2013","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1016\/j.ahj.2017.06.011_bb0185","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4244\/EIJY14M12_01","article-title":"Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study","volume":"10","author":"Sievert","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2017.06.011_bb0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijcard.2015.08.069","article-title":"Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system","volume":"201","author":"Tsioufis","year":"2015","journal-title":"Int J Cardiol"},{"issue":"22","key":"10.1016\/j.ahj.2017.06.011_bb0195","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317301849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317301849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:58:45Z","timestamp":1757570325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317301849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":39,"alternative-id":["S0002870317301849"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.06.011","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}